Samsung Biologics announces strategic agreement with Bristol Myers Squibb
Samsung Biologics has officially announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol …
Samsung Biologics
Samsung Biologics Ranks Second Among the Most Trusted Healthcare and Life Services Companies
According to the latest information, Samsung Biologics secured the second position in the Most Trustworthy Companies in Healthcare and …
Samsung Biologics, Pfizer disclosed strategic partnership
Samsung Biologics and Pfizer revealed a strategic partnership recently on June 8. This is for the long-term contract …
Samsung Biologics faced another patent infringement lawsuit
Samsung Biologics has reportedly got another patent lawsuit. Back in January, US pharmaceutical company Regeneron filed a patent …
In Q1 2023 Samsung Biologics recorded a revenue of KRW 720.9 billion
In Q1 2023 Samsung Biologics recorded a revenue of KRW 720.9 billionand an operating profit of KRW 191.7 …
Samsung Biologics receives the Sustainable Markets Initiative’s Terra Carta Seal
Samsung Biologics is a leading contract development and manufacturing organization (CDMO). It has received the Sustainable Markets Initiative’s …